Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06194539

Assessing the Fertility Status of Men With Spinal Muscular Atrophy (SMA)

The Assessment of Fertility in Men With Spinal Muscular Atrophy (SMA)

Status
Recruiting
Phase
Study type
Observational
Enrollment
75 (estimated)
Sponsor
Bar-Chama, Natan, M.D. · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers

Summary

This study will aim to assess the fertility status of men with Spinal Muscular Atrophy (SMA) not on disease-modifying therapies. Participants will: 1. Complete online questionnaires that will assess SMA diagnosis and disease burden, medical and surgical history, medication usage, and fertility status and perspectives. 2. Over the 3-month initial study baseline period participants will provide two separate ejaculates for semen analysis and a single determination of sperm quality using DNA fragmentation testing using home collection and subsequent shipment to a central laboratory. 3. Over the initial study baseline period of 3 months study participants will obtain a blood test to determine male reproductive hormone levels. During the 24-month study duration, participants will be requested to undergo a yearly semen analysis and complete online relevant questionnaires.

Detailed description

Study participants will: 1. Complete online questionnaires that will assess SMA diagnosis and disease burden, medical and surgical history, medication usage, and fertility status and perspectives. 2. Over the 3-month initial study baseline period participants will provide two separate ejaculates for semen analysis and a single determination of sperm quality using DNA fragmentation testing using home collection and subsequent shipment to a central laboratory. 3. Over the initial study baseline period of 3 months study participants will obtain a blood test to determine male reproductive hormone levels. During the 24-month study duration, participants will be requested to undergo a yearly semen analysis and complete online relevant questionnaires.

Conditions

Timeline

Start date
2024-02-01
Primary completion
2026-02-01
Completion
2026-07-01
First posted
2024-01-08
Last updated
2024-01-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06194539. Inclusion in this directory is not an endorsement.